Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -820.95x is 720% below its 4-year average of -100.07x, near the low end of its 4-year range (-820.95x–-4.19x).
As of the fiscal period ended Thursday, September 30, 2021.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -820.95x.
INTEREST COVERAGE RATIO
-820.95x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-112.63x
INTEREST COVERAGE RATIO AVG 5Y
-100.07x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-628.90%
CURRENT VS 5Y AVG
-720.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-12647.63%
vs the sector median at left
Xenon Pharmaceuticals Inc.
Market Cap
$3.54B
Interest Coverage Ratio
-820.95x
TTM Avg
N/A
3Y Avg
-112.63x
5Y Avg
-100.07x
Market Cap
$3.52B
Interest Coverage Ratio
-2.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.56B
Interest Coverage Ratio
N/A
TTM Avg
8071.00x
3Y Avg
8071.00x
5Y Avg
8071.00x
Market Cap
$3.57B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.44B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.64B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | $3.54B | -820.95x | N/A | -112.63x | -100.07x |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -2.80x | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.56B | N/A | 8071.00x | 8071.00x | 8071.00x |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | -10.04x | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | N/A | N/A | N/A | N/A |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | N/A | 407.95x | 407.95x | 407.95x |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | -99.92x | N/A | N/A | N/A |
Interest Coverage
-820.9x
Debt/Equity
0.01
Current Ratio
21.02
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -820.95x |
| 2020-06-30 | -4.19x |
| 2020-03-31 | -24.34x |
| 2019-12-31 | -33.33x |
| 2019-09-30 | -24.66x |
| 2019-06-30 | -28.80x |
| 2019-03-31 | -32.84x |
| 2018-12-31 | -23.62x |
| 2018-09-30 | -20.91x |
| 2018-06-30 | -37.93x |
| 2018-03-31 | -49.17x |
| 2013-12-31 | 252.38x |
| 2013-09-30 | 434.60x |
